Literature DB >> 27271264

Muscle electrical stimulation improves neurovascular control and exercise tolerance in hospitalised advanced heart failure patients.

Raphaela V Groehs1, Ligia M Antunes-Correa1, Thais S Nobre1, Maria-Janieire Nn Alves1, Maria Urbana Pb Rondon2, Antônio Carlos Pereira Barreto1, Carlos E Negrão3.   

Abstract

BACKGROUND: We investigated the effects of muscle functional electrical stimulation on muscle sympathetic nerve activity and muscle blood flow, and, in addition, exercise tolerance in hospitalised patients for stabilisation of heart failure.
METHODS: Thirty patients hospitalised for treatment of decompensated heart failure, class IV New York Heart Association and ejection fraction ≤ 30% were consecutively randomly assigned into two groups: functional electrical stimulation (n = 15; 54 ± 2 years) and control (n = 15; 49 ± 2 years). Muscle sympathetic nerve activity was directly recorded via microneurography and blood flow by venous occlusion plethysmography. Heart rate and blood pressure were evaluated on a beat-to-beat basis (Finometer), exercise tolerance by 6-minute walk test, quadriceps muscle strength by a dynamometer and quality of life by Minnesota questionnaire. Functional electrical stimulation consisted of stimulating the lower limbs at 10 Hz frequency, 150 ms pulse width and 70 mA intensity for 60 minutes/day for 8-10 consecutive days. The control group underwent electrical stimulation at an intensity of < 20 mA.
RESULTS: Baseline characteristics were similar between groups, except age that was higher and C-reactive protein and forearm blood flow that were smaller in the functional electrical stimulation group. Functional electrical stimulation significantly decreased muscle sympathetic nerve activity and increased muscle blood flow and muscle strength. No changes were found in the control group. Walking distance and quality of life increased in both groups. However, these changes were greater in the functional electrical stimulation group.
CONCLUSION: Functional electrical stimulation improves muscle sympathetic nerve activity and vasoconstriction and increases exercise tolerance, muscle strength and quality of life in hospitalised heart failure patients. These findings suggest that functional electrical stimulation may be useful to hospitalised patients with decompensated chronic heart failure. © The European Society of Cardiology 2016.

Entities:  

Keywords:  Heart failure; electrical stimulation; exercise tolerance; sympathetic nerve activity; vasoconstriction

Mesh:

Year:  2016        PMID: 27271264     DOI: 10.1177/2047487316654025

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  14 in total

1.  Exercise therapy and autonomic function in heart failure patients: a systematic review and meta-analysis.

Authors:  M J Pearson; N A Smart
Journal:  Heart Fail Rev       Date:  2018-01       Impact factor: 4.214

Review 2.  Exercise intervention in hospitalized heart failure patients, with emphasis on congestion-related complications: a review.

Authors:  Jirka Cops; Sibren Haesen; Bart De Moor; Wilfried Mullens; Dominique Hansen
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

3.  In-hospital electrical muscle stimulation for patients early after heart failure decompensation: results from a prospective randomised controlled pilot trial.

Authors:  Maria Poltavskaya; Victoria Sviridenko; Ilya Giverts; Irina Patchenskaya; Inesa Kozlovskaya; Elena Tomilovskaya; Gabil Orkhan Veliyev; Denis Andreev; Abram Syrkin; Hugo Saner
Journal:  Open Heart       Date:  2022-07

4.  Effect of exercise training on cardiovascular autonomic and muscular function in subclinical Chagas cardiomyopathy: a randomized controlled trial.

Authors:  Adriana Oliveira Sarmento; Ligia M Antunes-Correa; Maria J N N Alves; Aline V N Bacurau; Keila C B Fonseca; Fernanda G Pessoa; Denise M L Lobo; Leila D P Moreira; Ivani C Trombetta; Maria U P B Rondon; Eduardo Rondon; Marcelo L C Vieira; Felix J A Ramires; Maria Socorro do Brasileiro-Santos; Patricia C Brum; Charles Mady; Carlos E Negrao; Scott Thomas; Barbara M Ianni
Journal:  Clin Auton Res       Date:  2020-09-01       Impact factor: 4.435

5.  Adjuvant Treatment with 5-Fluorouracil and Oxaliplatin Does Not Influence Cardiac Function, Neurovascular Control, and Physical Capacity in Patients with Colon Cancer.

Authors:  Raphaela V Groehs; Marcelo V Negrao; Ludhmila A Hajjar; Camila P Jordão; Bruna P Carvalho; Edgar Toschi-Dias; Ana C Andrade; Fabiana P Hodas; Maria J N N Alves; Adriana O Sarmento; Laura Testa; Paulo M G Hoff; Carlos E Negrao; Roberto Kalil Filho
Journal:  Oncologist       Date:  2020-08-31

6.  Effects of Acute Phase Intensive Electrical Muscle Stimulation in Frail Elderly Patients With Acute Heart Failure (ACTIVE-EMS): Rationale and protocol for a multicenter randomized controlled trial.

Authors:  Shinya Tanaka; Kentaro Kamiya; Yuya Matsue; Ryusuke Yonezawa; Hiroshi Saito; Nobuaki Hamazaki; Ryota Matsuzawa; Kohei Nozaki; Kazuki Wakaume; Yoshiko Endo; Emi Maekawa; Minako Yamaoka-Tojo; Takaaki Shiono; Takayuki Inomata; Takashi Masuda; Junya Ako
Journal:  Clin Cardiol       Date:  2017-12-16       Impact factor: 2.882

Review 7.  Is Exercise Training Appropriate for Patients With Advanced Heart Failure Receiving Continuous Inotropic Infusion? A Review.

Authors:  Eisuke Amiya; Masanobu Taya
Journal:  Clin Med Insights Cardiol       Date:  2018-01-03

Review 8.  Exercise and heart failure: an update.

Authors:  Gaia Cattadori; Chiara Segurini; Anna Picozzi; Luigi Padeletti; Claudio Anzà
Journal:  ESC Heart Fail       Date:  2017-12-13

9.  Safety and Efficacy of Aerobic Exercise Training Associated to Non-Invasive Ventilation in Patients with Acute Heart Failure.

Authors:  Mayron F Oliveira; Rita C Santos; Suellen A Artz; Vanessa M F Mendez; Denise M L Lobo; Edileide B Correia; Almir S Ferraz; Iracema I K Umeda; Priscila A Sperandio
Journal:  Arq Bras Cardiol       Date:  2018-03-12       Impact factor: 2.000

10.  Effects of aerobic and inspiratory training on skeletal muscle microRNA-1 and downstream-associated pathways in patients with heart failure.

Authors:  Ligia M Antunes-Correa; Patricia F Trevizan; Aline V N Bacurau; Larissa Ferreira-Santos; João L P Gomes; Ursula Urias; Patricia A Oliveira; Maria Janieire N N Alves; Dirceu R de Almeida; Patricia C Brum; Edilamar M Oliveira; Ludhmila Hajjar; Roberto Kalil Filho; Carlos Eduardo Negrão
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-11-19       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.